KD025: Clinical Trials

1 trial of KD025, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow KD025: new trials by email Literature Review of KD025 trials Research Report on KD025

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
Belumosudil, Placebo, Prednisone - Chronic Graft Versus Host Disease
Phase 3Active not recruitingSanofi2602024-01-232026-10-16

Conditions studied

Bronchiolitis Obliterans Syndrome (1)

Sponsors

Sanofi (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  Israel (1)  ·  Italy (1)

NIH funding

2023 (1)